Summit Trail Advisors, LLC - BRIACELL THERAPEUTICS CORP ownership

BRIACELL THERAPEUTICS CORP's ticker is BCTX and the CUSIP is 10778Y302. A total of 24 filers reported holding BRIACELL THERAPEUTICS CORP in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.3%.

Quarter-by-quarter ownership
Summit Trail Advisors, LLC ownership history of BRIACELL THERAPEUTICS CORP
ValueSharesWeighting
Q2 2023$224,700
-13.8%
35,0000.0%0.01%
-27.3%
Q1 2023$260,750
+70.5%
35,0000.0%0.01%
+57.1%
Q4 2022$152,950
-22.4%
35,0000.0%0.01%
-36.4%
Q3 2022$197,000
-2.5%
35,0000.0%0.01%
-8.3%
Q2 2022$202,000
-43.1%
35,0000.0%0.01%
-58.6%
Q1 2022$355,000
+22.4%
35,0000.0%0.03%
+52.6%
Q4 2021$290,000
+2.1%
35,0000.0%0.02%
-9.5%
Q3 2021$284,000
+51.9%
35,0000.0%0.02%
+31.2%
Q2 2021$187,00035,0000.02%
Other shareholders
BRIACELL THERAPEUTICS CORP shareholders Q4 2022
NameSharesValueWeighting ↓
Redmond Asset Management, LLC 136,593$1,106,0000.35%
Total Clarity Wealth Management, Inc. 11,425$93,0000.04%
Virtu Financial LLC 32,952$267,0000.02%
Apollon Wealth Management, LLC 19,400$157,0000.02%
Summit Trail Advisors, LLC 35,000$284,0000.02%
FNY Investment Advisers, LLC 4,687$37,0000.02%
Freedom Investment Management, Inc. 16,649$135,0000.01%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 156,946$1,271,0000.01%
Belvedere Trading LLC 13,608$107,0000.00%
GOFEN & GLOSSBERG LLC /IL/ 10,000$81,0000.00%
View complete list of BRIACELL THERAPEUTICS CORP shareholders